PARTNER 3 Trial: What Have We Learned and How Will This Impact Patient Care?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

PARTNER 3 Trial: What Have We Learned and How Will This Impact Patient Care?

By Cleveland Clinic Heart, Vascular and Thoracic Institute FEATURING Samir Kapadia, Lars Svensson

30 views

October 29, 2019

Description: Dr. Lars Svensson, Chairman of the Heart and Vascular Institute and Dr. Samir Kapadia, ...
read more ↘ Section Head, Interventional Cardiology have been involved with PARTNER trials over many years. Together, they discuss the history of the PARTNER Transcatheter aortic valve replacement (TAVR) trials, the results of the low risk PARTNER 3 trial and its impact on patient care, additional trials of interest such as the TAVR UNLOAD trial for heart failure patients and EARLY TAVR for asymptomatic AS.
↖ read less

0 Comments